查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1587830

被忽視的熱帶疾病治療市場規模、佔有率、趨勢分析報告：按疾病、產品、地區和細分市場預測，2024-2030 年

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

被忽視的熱帶疾病治療市場的成長和趨勢

Grand View Research, Inc.最新報告顯示，到2030年，全球被忽視的熱帶疾病治療市場規模預計將達到52.5億美元，預測期內複合年成長率為4.8%。

被忽視的熱帶疾病的日益流行被認為是造成影響的關鍵促進因素。

根據世界衛生組織2018年發表的資料，岡比亞結核病在中非和西非24個國家流行。大約 98% 的昏睡病報告病例都是由這種原因引起的。此外，據 CDC 稱，登革熱每年感染約 400 人。

此外，根據世界衛生組織2019年發布的統計數據，超過15億人，即世界人口的24%，感染了土源性蠕蟲病。這些感染疾病廣泛分佈於熱帶和亞熱帶地區，主要發生在美洲、撒哈拉以南非洲、東亞和中國。

正在研發的疫苗和藥物也被認為是預測期內推動市場成長的關鍵因素之一。例如，拜耳公司正在開發硝呋替莫（BAYA2502），目前正處於治療南美錐蟲病的 III 期臨床試驗中。此外，強生服務公司正在開發一種200毫克貝達奎林單藥治療方案，用於治療痲瘋病的II期臨床試驗，預計將於2021年完成。

此外，Instituto Butantan 和默克公司於 2018 年合作開發了一種針對登革熱的疫苗。 Instituto Butantan 正在巴西開發登革熱候選疫苗 TV003，目前正在進行第 3 期臨床試驗。默克公司 (Merck & Co., Inc.) 列出了 Instituto Butantan 的發展基金。

F. Hoffmann-La Roche Ltd、Bayer AG、GlaxoSmithKline plc、Novartis AG、Pfizer, Inc.、Eisai Co. Ltd.、Sanofi、Astellas Pharma、Takeda Pharmaceutical Company Limited、Gilead Sciences 將推動整體市場成長這些公司參與新產品市場開拓被認為是熱帶疾病治療市場的成長要素。

熱帶疾病治療市場報告亮點

  • 由於發病率不斷上升，登革熱在 2023 年佔據了最大的細分市場。
  • 由於人們對該疾病的認知不斷增強，預計布魯裡潰瘍將成為預測期內成長最快的部分。
  • 到2023年，藥品預計將成為最大的產品領域。
  • 由於研發線產品的強勁存在，疫苗預計將成為預測期內成長最快的部分。
  • 2023 年，亞太地區將主導被忽視的熱帶疾病治療市場。
  • 預計拉丁美洲將在預測期內經歷最快的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章被忽視的熱帶疾病治療市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 被忽視的熱帶疾病治療市場分析工具
    • 波特的分析
    • PESTEL分析

第4章被忽視的熱帶疾病治療市場：按產品估計和趨勢分析

  • 細分儀表板
  • 被忽視的熱帶疾病治療市場：產品變化分析，百萬美元，2023 年和 2030 年
  • 藥品
    • 寄生蟲控制
    • 抗真菌劑
    • 抗生素
    • 其他
  • 疫苗

第5章被忽視的熱帶疾病治療市場：按疾病分類的估計和趨勢分析

  • 細分儀表板
  • 被忽視的熱帶疾病治療市場：疾病變化分析，百萬美元，2023 年和 2030 年
  • 登革熱
  • 狂犬病
  • 沙眼
  • 布魯裡潰瘍
  • 草莓瘤
  • 麻風
  • 南美錐蟲病
  • 人類非洲錐蟲病
  • 利什曼原蟲症

第6章被忽視的熱帶疾病治療市場：區域估計和趨勢分析

  • 2023 年和 2030 年被忽視的熱帶疾病治療市場佔有率（按地區分類），百萬美元。
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer, Inc
    • Eisai Co. Ltd.
    • Sanofi.
    • Astellas Pharma
    • Takeda Pharmaceutical Company Limited
    • Gilead Sciences
Product Code: GVR-3-68038-787-2

Neglected Tropical Disease Treatment Market Growth & Trends:

The global neglected tropical disease treatment market size is expected to reach USD 5.25 billion by 2030, expanding at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of neglected tropical diseases is considered to be the vital impact rendering driver.

According to the data published in the WHO in 2018, T.B. Gambiense is endemic in 24 countries of Central and West Africa. This caused around 98% of reported cases of sleeping sickness. Furthermore, according to the CDC, around 400 people are infected annually by dengue.

Moreover, according to the statistics published in the WHO in 2019, more than 1.5 billion or 24% of the world's population are infected with soil-transmitted helminthiases. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China.

Presence of pipeline vaccines and drugs is also considered to be one of the major factors driving the market growth over the forecast period. For instance, Bayer AG is developing Nifurtimox (BAYA2502), currently under phase III clinical trials for the treatment of Chagas disease. Furthermore, Johnson & Johnson Services Inc. is developing Bedaquiline 200mg monotherapy regimen which is under phase II clinical trials for the treatment of leprosy and the study is estimated to be completed in 2021.

In addition, Instituto Butantan and Merck & Co., Inc. collaborated to develop vaccines against dengue in 2018. The Instituto Butantan is developing a dengue vaccine candidate in Brazil, TV003, which is in an ongoing Phase III clinical trial. Merck & Co., Inc. will provide funds to Instituto Butantan for its development.

Presence of key players such as F. Hoffmann-La Roche Ltd, Bayer AG, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Eisai Co. Ltd., Sanofi, Astellas Pharma, Takeda Pharmaceutical Company Limited, and Gilead Sciences is expected to fuel to the overall market growth. Involvement of these players in new product development is considered to be the contributing factor for the NTD treatment market.

Tropical Disease Treatment Market Report Highlights:

  • Dengue held the largest segment share in 2023 owing to its increasing prevalence rate
  • Buruli ulcer is estimated to be the fastest growing segment over the forecast period owing to rising awareness about the disease
  • In 2023, drugs were anticipated to be the largest product segment
  • Vaccines are estimated to be the fastest growing segment over the forecast period due to strong presence of pipeline products
  • Asia Pacific dominated the neglected tropical disease treatment market in 2023
  • Latin America is estimated to witness the fastest growth over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neglected Tropical Disease Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neglected Tropical Disease Treatment Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neglected Tropical Disease Treatment Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Drugs
    • 4.3.1. Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Anti-Parasite
      • 4.3.2.1. Anti-Parasite Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Antifungal
      • 4.3.3.1. Antifungal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Antibiotics
      • 4.3.4.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Vaccines
    • 4.4.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neglected Tropical Disease Treatment Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neglected Tropical Disease Treatment Market: Disease Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Dengue
    • 5.3.1. Dengue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Rabies
    • 5.4.1. Rabies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Trachoma
    • 5.5.1. Trachoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Buruli Ulcer
    • 5.6.1. Buruli Ulcer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Yaws
    • 5.7.1. Yaws Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Leprosy
    • 5.8.1. Leprosy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Chagas Disease
    • 5.9.1. Chagas Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Human African Trypanosomiasis
    • 5.10.1. Human African Trypanosomiasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Leishmaniases
    • 5.11.1. Leishmaniases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Neglected Tropical Disease Treatment Market Share, By Region, 2023 & 2030, USD Million.
  • 6.2. North America
    • 6.2.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. UAE
      • 6.6.2.1. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. F. Hoffmann-La Roche Ltd
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Bayer AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. GlaxoSmithKline plc
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Novartis AG
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Pfizer, Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Eisai Co. Ltd.,
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Sanofi.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Astellas Pharma
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Takeda Pharmaceutical Company Limited
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Gilead Sciences
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 North America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 3 North America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 4 U.S. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 5 U.S. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 6 Canada Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 7 Canada Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 8 Europe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 9 Europe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 10 U.K. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 11 U.K. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 12 Germany Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 13 Germany Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 14 Asia Pacific Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 15 Asia Pacific Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 16 Japan Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 17 Japan Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 18 China Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 19 China Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 20 India Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 21 India Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 22 Indonesia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 23 Indonesia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 24 Singapore Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 25 Singapore Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 26 Philippines Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 27 Philippines Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 28 Latin America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 29 Latin America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 30 Mexico Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 31 Mexico Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 32 Brazil Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 33 Brazil Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 34 Argentina Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 35 Argentina Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 36 Colombia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 37 Colombia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 38 Bolivia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 39 Bolivia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 40 MEA Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 41 MEA Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 42 South Africa Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 43 South Africa Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 44 Saudi Arabia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 45 Saudi Arabia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 46 UAE Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 47 UAE Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 48 Nigeria Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 49 Nigeria Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 50 Ghana Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 51 Ghana Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 52 Zimbabwe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 53 Zimbabwe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global Neglected Tropical Disease Treatment market- Key market driver analysis
  • FIG. 7 Global Neglected Tropical Disease Treatment market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global Neglected Tropical Disease Treatment market - Porter's analysis
  • FIG. 10 Global Neglected Tropical Disease Treatment market - PESTEL analysis
  • FIG. 11 Global Neglected Tropical Disease Treatment market disease outlook key takeaways
  • FIG. 12 Global Neglected Tropical Disease Treatment market: Disease movement analysis
  • FIG. 13 Dengue market estimates, 2018 - 2030 (USD Million)
  • FIG. 14 Rabies market estimates, 2018 - 2030 (USD Million)
  • FIG. 15 Trachoma market estimates, 2018 - 2030 (USD Million)
  • FIG. 16 Buruli ulcer market estimates, 2018 - 2030 (USD Million)
  • FIG. 17 Yaw's market estimates, 2018 - 2030 (USD Million)
  • FIG. 18 Leprosy market estimates, 2018 - 2030 (USD Million)
  • FIG. 19 Chagas disease market estimates, 2018 - 2030 (USD Million)
  • FIG. 20 Human African trypanosomiasis (sleeping sickness) market estimates, 2018 - 2030 (USD Million)
  • FIG. 21 Leishmaniases market estimates, 2018 - 2030 (USD Million)
  • FIG. 22 Soil-transmitted helminthiases market estimates, 2018 - 2030 (USD Million)
  • FIG. 23 Others market estimates, 2018 - 2030 (USD Million)
  • FIG. 24 Global Neglected Tropical Disease Treatment market Product type outlook key takeaways
  • FIG. 25 Global Neglected Tropical Disease Treatment market: Product type movement analysis
  • FIG. 26 Drugs market estimates, 2018 - 2030 (USD Million)
  • FIG. 27 Vaccines market estimates, 2018 - 2030 (USD Million)
  • FIG. 28 Regional marketplace: Key takeaways
  • FIG. 29 Global Neglected Tropical Disease Treatment market: Regional movement analysis
  • FIG. 30 North America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 31 U.S. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 32 Canada Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 33 Europe Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 34 U.K. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 35 Germany Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 36 Asia Pacific Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 37 Japan Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 38 China Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 39 India Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 40 Indonesia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 41 Singapore Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 42 Philippines Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 43 Latin America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG 44 Brazil Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 45 Mexico Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 46 Argentina Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 47 Colombia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 48 Bolivia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million
  • FIG. 49 MEA Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 50 South Africa Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 51 Saudi Arabia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 52 UAE market, 2018 - 2030 (USD Million)
  • FIG. 53 Nigeria market, 2018 - 2030 (USD Million)
  • FIG. 54 Ghana market, 2018 - 2030 (USD Million)
  • FIG. 55 Zimbabwe market, 2018 - 2030 (USD Million)
  • FIG. 56 Strategy framework